Trial intelligence / Profile preview

Comparison of adductor pollicis vs abductor digiti minimi recovery from rocuronium in elderly patients

jRCT1032250378Completed

Start
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of rocuronium in None. Primary endpoint: Time from rocuronium administration to TOF ratio 0.9. Started Sep 2025; status: completed.

02

Drugs

rocuronium

Beyond the preview

Go deeper on jRCT1032250378.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1032250378.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call